SOLIGENIX INC

For the period ended Dec 31, 2023. Filed Mar 15, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 15, 2024

SNGX$0.34+0.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item · Description · Page
Cautionary Note Regarding Forward-Looking Statements · · ii
	Part I
1.	Business	1
1A.	Risk Factors	27
1B.	Unresolved Staff Comments	51
1C	Cybersecurity	51
2.	Properties	52
3.	Legal Proceedings	52
	Part II
5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	53
6.	Selected Financial Data	54
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	54
8.	Financial Statements and Supplementary Data	63
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	63
9A.	Controls and Procedures	64
9B.	Other Information	65
9C.	Disclosure Regarding Foreign Jurisdictions	65
	Part III
10.	Directors, Executive Officers and Corporate Governance	66
11.	Executive Compensation	71
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	75
13.	Certain Relationships and Related Transactions and Director Independence	77
14.	Principal Accountant Fees and Services	78
	Part IV
15.	Exhibits and Financial Statement Schedules	78
Signatures	83
Consolidated Financial Statements	F-1

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents